Pfizer Inc at Handelsbanken Life Science Innovation Day (Virtual) Transcript
¤ -
So good morning for those of you in the U.S. and good afternoon for those of you joining here in Europe. So my name is Mattias Häggblom. I'm Sector Head of Healthcare Research here at Handelsbanken, and welcome to the final but perhaps most important session at our second annual Life Science and Innovation Day.
It's a great honor to welcome Mikael Dolsten, Chief Scientific Officer, President, Worldwide Research, Development and Medical at Pfizer, as our keynote speaker to this year's Innovation Day. And what better fits by ending an event focused on innovation to bring a company who played a crucial role and continues to do so in the fight against COVID-19, both with the vaccine but also an antiviral.
Before I start my discussion with Mikael, I'm going to hand over to Chris Stevo, Head of IR at Pfizer, who's going to help us with some of the disclaimers around forward-looking statements. Chris, over to you.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
